FDA Office of Orphan Products
Investments
1
Lead Investments
1
The FDA Office of Orphan Products Development (OOPD) is dedicated to promoting the development and evaluation of new treatments for rare diseases. It supports the development of safe and effective medical products through grants and designations for orphan drugs and biological products.
Highlights
Focus Areas
Biotechnology
Clinical Trials
Therapeutics
Notable Investments
